Non-Invasive Determination of Fetal Chromosome Abnormalities
Sponsor
Lenetix Medical Screening Laboratory (Industry)
Overall Status
Unknown status
CT.gov ID
NCT00891852
Collaborator
(none)
1,000
7
11
142.9
13
Study Details
Study Description
Brief Summary
The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1000 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Non-Invasive Determination of Fetal Chromosome Abnormalities
Study Start Date
:
Jan 1, 2009
Anticipated Primary Completion Date
:
Dec 1, 2009
Anticipated Study Completion Date
:
Dec 1, 2009
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- This study is only applicable to women who are between 8 and 30 weeks' gestation and who have been determined increased risk for fetal aneuploidy. In the interest of expediting and simplifying this study, the investigators want only women who have already decided to undergo second-trimester amniocentesis or CVS.
Exclusion Criteria:
- The only exclusion criteria are those mentioned.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Maryland Perinatal Associates | Rockville | Maryland | United States | 20850 |
2 | Atlantic Maternal Fetal Medicine | Moristown | New Jersey | United States | 07960 |
3 | Winthrop University Hospital | Mineola | New York | United States | 11501 |
4 | Elite Women's Health | New Hyde Park | New York | United States | 11042 |
5 | Columbia University, NewYork-Presbyterian Hospital | New York | New York | United States | 10022 |
6 | New York Perinatal Associates | New York | New York | United States | 10128 |
7 | UVM | Burlington | Vermont | United States | 05405 |
Sponsors and Collaborators
- Lenetix Medical Screening Laboratory
Investigators
- Principal Investigator: Stephen A Brown, MD, Lenetix, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00891852
Other Study ID Numbers:
- 110106-1
First Posted:
May 1, 2009
Last Update Posted:
May 1, 2009
Last Verified:
Apr 1, 2009
Additional relevant MeSH terms: